Wockhardt's recombinant insulin analogue

· Wockhardt

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Wockhardt's recombinant insulin analogue, covering 2019-10-08 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients [Phase 3]